US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 2.9800
  • -0.0200-0.67%
Close Apr 16 16:00 ET
  • 2.9600
  • -0.0200-0.67%
Post 18:58 ET
76.30MMarket Cap-748P/E (TTM)

Leap Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
57.08%85.94M
12.72%14.84M
-2.44%14.28M
-11.95%14.36M
300.70%42.45M
31.20%54.71M
17.35%13.17M
30.14%14.64M
67.19%16.31M
11.81%10.6M
Selling and administrative expenses
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
30.68%3.19M
2.15%2.86M
3.94%2.85M
-General and administrative expense
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
30.68%3.19M
2.15%2.86M
3.94%2.85M
Research and development costs
62.87%73.23M
5.90%11.69M
-4.95%11.5M
-20.94%11.1M
400.28%38.94M
39.82%44.97M
36.73%11.03M
20.10%12.1M
94.91%14.05M
14.35%7.78M
Other operating expenses
46.32%-1.1M
102.97%23K
15.03%-554K
49.23%-298K
-635.14%-272K
-67.29%-2.05M
-316.48%-775K
48.62%-652K
-140.57%-587K
47.89%-37K
Operating profit
-57.08%-85.94M
-12.72%-14.84M
2.44%-14.28M
11.95%-14.36M
-300.70%-42.45M
-36.10%-54.71M
-21.41%-13.17M
-34.63%-14.64M
-73.88%-16.31M
-16.42%-10.6M
Net non-operating interest income expense
362.34%4.03M
81.78%938K
210.60%1.08M
5,159.09%1.16M
5,400.00%848K
2,821.88%871K
17,100.00%516K
4,462.50%349K
246.67%22K
-33.33%-16K
Non-operating interest income
335.35%4.03M
80.04%938K
201.11%1.08M
2,866.67%1.16M
16,860.00%848K
10,177.78%925K
10,320.00%521K
35,900.00%360K
3,800.00%39K
150.00%5K
Non-operating interest expense
--0
--0
--0
--0
--0
31.71%54K
150.00%5K
22.22%11K
6.25%17K
50.00%21K
Other net income (expense)
182.07%499K
106.60%1.44M
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
-210.38%-807K
-468.22%-733K
1,219.05%235K
Gain on sale of security
99.84%-1K
34.86%940K
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
-210.38%-807K
-468.22%-733K
1,219.05%235K
Other non- operating income (expenses)
--500K
----
----
----
----
----
----
----
----
----
Income before tax
-49.52%-81.41M
-4.27%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.07%-54.45M
-10.57%-11.96M
-35.51%-15.09M
-78.71%-17.02M
-13.60%-10.38M
Income tax
0
712.50%147K
Net income
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
-13.60%-10.38M
Net income continuous Operations
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
-13.60%-10.38M
Minority interest income
Net income attributable to the parent company
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
-13.60%-10.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
-13.60%-10.38M
Basic earnings per share
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-255.56%-3.2
-2.55%-4.82
-10.00%-1.1
5.00%-1.33
-25.00%-1.5
25.00%-0.9
Diluted earnings per share
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-255.56%-3.2
-2.55%-4.82
-10.00%-1.1
5.00%-1.33
-25.00%-1.5
25.00%-0.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 57.08%85.94M12.72%14.84M-2.44%14.28M-11.95%14.36M300.70%42.45M31.20%54.71M17.35%13.17M30.14%14.64M67.19%16.31M11.81%10.6M
Selling and administrative expenses 17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M30.68%3.19M2.15%2.86M3.94%2.85M
-General and administrative expense 17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M30.68%3.19M2.15%2.86M3.94%2.85M
Research and development costs 62.87%73.23M5.90%11.69M-4.95%11.5M-20.94%11.1M400.28%38.94M39.82%44.97M36.73%11.03M20.10%12.1M94.91%14.05M14.35%7.78M
Other operating expenses 46.32%-1.1M102.97%23K15.03%-554K49.23%-298K-635.14%-272K-67.29%-2.05M-316.48%-775K48.62%-652K-140.57%-587K47.89%-37K
Operating profit -57.08%-85.94M-12.72%-14.84M2.44%-14.28M11.95%-14.36M-300.70%-42.45M-36.10%-54.71M-21.41%-13.17M-34.63%-14.64M-73.88%-16.31M-16.42%-10.6M
Net non-operating interest income expense 362.34%4.03M81.78%938K210.60%1.08M5,159.09%1.16M5,400.00%848K2,821.88%871K17,100.00%516K4,462.50%349K246.67%22K-33.33%-16K
Non-operating interest income 335.35%4.03M80.04%938K201.11%1.08M2,866.67%1.16M16,860.00%848K10,177.78%925K10,320.00%521K35,900.00%360K3,800.00%39K150.00%5K
Non-operating interest expense --0--0--0--0--031.71%54K150.00%5K22.22%11K6.25%17K50.00%21K
Other net income (expense) 182.07%499K106.60%1.44M37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K-210.38%-807K-468.22%-733K1,219.05%235K
Gain on sale of security 99.84%-1K34.86%940K37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K-210.38%-807K-468.22%-733K1,219.05%235K
Other non- operating income (expenses) --500K------------------------------------
Income before tax -49.52%-81.41M-4.27%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.07%-54.45M-10.57%-11.96M-35.51%-15.09M-78.71%-17.02M-13.60%-10.38M
Income tax 0712.50%147K
Net income -49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M-13.60%-10.38M
Net income continuous Operations -49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M-13.60%-10.38M
Minority interest income
Net income attributable to the parent company -49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M-13.60%-10.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M-13.60%-10.38M
Basic earnings per share 17.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-255.56%-3.2-2.55%-4.82-10.00%-1.15.00%-1.33-25.00%-1.525.00%-0.9
Diluted earnings per share 17.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-255.56%-3.2-2.55%-4.82-10.00%-1.15.00%-1.33-25.00%-1.525.00%-0.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg